The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer

Simon Gebremeskel, Terry Levatte, Robert S. Liwski, Brent Johnston, Michael Bezuhly

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science